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LEAD EXPOSURE AND METABOLIC SYNDROM
Abstract
Background: Lead is a known endocrine disruptor and can impair regulation of blood glucose,
blood pressure, abdominal adiposity, blood lipid levels which are risk factors for metabolic
syndrome (MetS).
Objective: To study the association of lead exposure and MetS in United States (U.S.) adults.
Methods: Data from 523 male and 528 female participants aged 20 years and older from the
2013 to 2014 National Health and Nutrition Examination Survey (NHANES) were analyzed.
Based on blood lead distribution in males and females, participants were categorized into low
and high blood lead groups in both genders. Adjusted logistic regression analysis was used to
determine association between lead exposure and MetS; controlling for age, ethnicity, income
and smoking status.
Results: The overall median blood lead levels for U.S. adults aged 20 years and older were 1.03
ug/dL; median blood lead levels were higher for males (1.23ug/dL) and lower for females (0.86
ug/dL). Prevalence of MetS in the male and female was 57.55% and 38.60%, respectively.
Compared to low blood lead groups, neither men nor women in high blood lead group showed
any elevated risk of MetS. The adjusted odds ratio (95% confidence interval) of MetS in males
was 0.741 (0.464-1.20), p-value: 0.209, in females it was 0.921 (0.563-1.51), p-value: 0.745.
Conclusion: For adults aged 20 years and older low median blood lead levels in the U.S. were
not significantly associated with MetS.
Keywords: metabolic syndrome, NHANES, blood lead levels, public health
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Lead Exposure and Metabolic Syndrome in U.S. Population, NHANES 2013-2014
Lead is a blue-gray metal that naturally occurs in all parts of our environment and is
found in small quantities in the earth’s crust (Shukla, Shukla, & Tiwari, 2018). Most of the lead
exposure seen today comes from human activities. Although the majority of these activities have
been either banned or restricted the burning of fossil fuels, mining and manufacturing have been
known leading contributors (Obeng-Gyasi, 2018).
Common sources of lead include household paint, petrol, industrial emissions, canning
and drinking water (Obeng-Gyasi, 2018). Government regulations has since restricted or limited
the usage or emission of lead as a means to curb the environmental and human burden of lead
exposure. The fate of inhaled or ingested lead or lead particles depends on several factors. The
bloodstream is the primary repository for absorbed lead and distributes lead through the body,
allowing for further absorption by other tissues (Centers for Disease Control and Prevention
[CDC], 2017). Lead is primarily housed in the blood, mineralized tissue (the bones and teeth)
and soft tissue (CDC, 2018). The amount of lead absorbed is dependent upon the route of
exposure. Small particles of lead found in dust can result in a higher absorption levels than lead
that may be ingested (CDC, 2017).
Lead is found in both organic and inorganic compounds (CDC, 2017). Organic lead
compounds, the type of lead found in petrol and used as additives, are metabolized in the liver
(Moon, 2013); whereas inorganic lead is not metabolized by the liver. In an adult human the
half-life of lead within the blood is estimated to be between 28 to 36 days (CDC, 2018).
Exposure to lead is measured using Blood Lead Levels (BLL) (CDC, 2017). It has been
estimated that 94% of the total lead body burden of adults is located in the bones and teeth
(CDC, 2017). Lead in mineralizing tissues are not distributed equally, lead accumulates in bones
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that are undergoing the most calcification at the time of exposure (CDC, 2017). Since lead is
stored in the bones symptoms of lead exposure can be present without significant current
exposure (CDC, 2018). Most instances of toxic BLL are from a mixture of current and previous
lead exposures (CDC, 2017). However, acute high rates of exposure can cause high short term
BLL’s and symptoms of lead poisoning (CDC, 2018).
Lead exposure continues to be a public health issue. As a heavy metal and an endocrine
disruptor, lead is associated with adverse human cardio metabolic outcomes such as high blood
pressure, increased Body Mass Index and high cholesterol (Grundy, Brewer, Cleeman, Smith, &
Lenfant, 2004). Metabolic syndrome (MetS) is a clustering of risk factors that predispose the
body to the development of cardiovascular disease (CVD) (Huang, 2009). Lead has been linked
with higher prevalence of MetS in Korean population (Rhee et al., 2013). The five components
that contribute to MetS are high blood pressure, high blood glucose levels, a larger waist
circumference, high blood lipid levels and lastly low high-density lipoproteins (HDL). The
presence of any three of these five components is considered MetS (Grundy et al., 2004). The
prevalence of MetS in the United States (U.S.) is estimated to be 33% (Aguilar, Bhuket, Torres,
Liu, & Wong, 2015), while the worldwide prevalence of MetS is estimated to be 25% (Nolan,
Carrick-Ranson, Stinear, Readings, & Dalleck, 2017). However, in the U.S. MetS prevalence in
regard to lead has not been explored in the general adult population. The present study aimed to
examine this question using data from National Health and Nutrition Examination Survey
(NHANES) 2013 to 2014.
Research Question
What effect does exposure to lead have on the development of MetS among the U.S.
population? It has been documented that lead is an endocrine disruptor and that disruption of the
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endocrine system has the potential to lead to MetS. Therefore, we hypothesize that there will be a
positive association between blood lead levels and MetS.
Literature Review
Lead Exposure
Lead is a naturally occurring metal in the environment which has been known to have
irreversible and toxic effects on the body. Mineral deposits within the Earth’s crust are a primary
source of the toxic heavy metal (Shukla et al., 2018). Lead is a persist heavy metal that can linger
in the environment, leaving populations to be potentially exposed in areas where lead may have
been previously deposited.
Exposure to lead can affect nearly all of the systems within the human body (CDC,
2018). Lead exposure can occur with no obvious signs and symptoms. In fact, lead has two
characteristics which are of great concern; it does not have a detectible taste or smell causing it
to frequently appear unrecognized until exposure related damage has occurred (Shukla et al.,
2018). Before U.S. policy changes primary sources of lead exposure were from petrol, industrial
emissions, household paint, food canning processing and drinking water. It was a widely held
belief that the lead content in petrol would improve the performance of engines in automobiles
(Obeng-Gyasi, 2018). This led to the respiratory absorption of lead from automobile emissions.
Once the harmful effects of breathing in lead from automobile emissions was recognized, new
government regulations enacted in the 1970’s pushed for the removal of lead from petrol
(Perron, Hartt, McCann, McGowan, & Segers, 2018). Also, in this era the government regulated
the output of industrial facilities in the hopes of decreasing environmental exposures of lead
(Perron et al., 2018). Paints containing lead where banned in 1978, while domestic food
processors voluntarily removed lead seals from their cans in the early 1990’s (Shukla et al.,

LEAD EXPOSURE AND METABOLIC SYNDROM

7

2018). Drinking water can be another source of lead exposure. Water can be contaminated at its
source by the environment or by pipes that are used to transport water, either because they are
made of lead or use lead components (Brochin et al., 2011).
There is no safe level of lead exposure, and even low levels can have an effect on one’s
health. The World Health Organization recommends that adults should have a blood lead
concentration below 10 μg/dL (CDC, 2018). The National Institute for Occupational Safety and
Health (NIOSH) also recommends that BLL for adults should be less than 10μg/dL, with adults
defined as those age sixteen years and older (CDC, 2018).
Absorption, Metabolism and Excretion
Absorption of lead can occur via the gastrointestinal tract by digestion through
contaminated foods, food preparation or storage containers or by lead particles on hands.
Inhalation of lead particles in dust is a pathway for lead to enter the body through the respiratory
system. Once absorbed by the body it can be stored in the soft tissues and bones (Leech, Adams,
Weathers, Staten, & Filippelli, 2016). BLL increases once exposure has occurred; however,
within one month these levels decrease as the lead is deposited into the bones. More than 90% of
the total bodily lead content is housed in the bones of the body where the half-life can be decades
long (Leech et al., 2016). Excretion of lead is through the hair, sweat and nails; the primary
excretion method however is in the urinary system.
Lead Health Effects
Lead exposure primarily affects the nervous system in both adults and in children;
however, in adult populations increased BLL is associated with cardiovascular disease,
hypertension, decreased renal function, increase in waist-to-hip ratio, and elevated blood lipid
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levels (Moon, 2013). The diseases and conditions associated with increased BLL’s are closely
tied to the endocrine function of the human body.
Impact of Lead on Endocrine Function
Bodily functions are controlled by a network of glands throughout the body, the
endocrine system. Two of the most important glands to the endocrine system are the
hypothalamus and the pituitary gland. The hypothalamus is responsible for maintaining the
stability of the internal environment, homeostasis. It is here that the nervous system and the
endocrine system are connected via the pituitary gland. The function of the pituitary gland is to
secrete hormones that release or inhibit hormones for bodily function (Brochin et al., 2011).
Some of the bodily functions controlled by hormones of the pituitary gland include: regulating
metabolism, triggering the release of cortisol (stress hormone), tissues of the liver, protein
synthesis, elevation of blood glucose levels, and maintenance of blood pressure (Brochin et al.,
2011).
The most detrimental effects of lead exposure are seen in the nervous system, where lead
blocks receptors in the brain that would naturally communicate to maintain normal bodily
functions (Brochin et al., 2011). The toxicity of lead disrupts the communication of the receptor
cells and crosses the blood-brain barrier (Brochin et al., 2011). Maintenance of the fluid
environment of the nervous system is one of the very important functions of the blood-brain
barrier. Unlike other organs in the body that transport molecules by simple diffusion, the bloodbrain barrier only uses certain essential molecules that are water-soluble to be transported by
carriers in the plasma membrane (Brochin et al., 2011). Exposure of high levels of lead causes
plasma to move into interstitial spaces of the brain causing edema (Brochin et al., 2011).
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The central nervous system and hormonal changes govern hunger, satiety, sleep patterns which
can impact metabolic functions such as blood glucose levels, blood pressure, and eating habits
that lead to increased waist circumference and blood lipid levels. These are all individual
components of the endocrine disorder metabolic syndrome (Huang, 2009). Exposure to lead
affects these individual components by way of the endocrine system. Increased blood glucose
levels have been associated with lead exposure; it is thought that chronic exposure to lead
inhibits the metabolism of glucose and lipids (Leff, Stemmer, Tyrrell, & Jog, 2018). In addition,
a study that examined exposure of heavy metals on human pancreatic function concluded that an
adverse correlation exists between heavy metal exposure and pancreatic function (Leff et al.,
2018). This evidence suggests that lead exposure can impact endocrine function of the pancreas
(Leff et al., 2018).
Effects on blood pressure. As previously discussed lead affect parts of the central
nervous system that regulates blood pressure levels. In addition, it has been hypothesized that the
damaging effects of lead on renal function is the primary cause of hypertension in those exposed
to lead (Gambelunghe et al., 2016). Other studies have concluded that lead inhibits the
compliance of vascular smooth muscles to contract and dilate in the cardiovascular system
essentially inhibiting the control of blood pressure (Kristal-Boneh, Coller, Froom, Harari, &
Ribak, 1999). In either instance the effects of lead exposure on the body’s ability to self-regulate
blood pressure have been explored and documented.
Effects on obesity. Lead exposure is also associated with obesity. The association of
obesity with increased waist circumference has also been well documented. Alterations in the
function of the hypothalamic-pituitary hormones have been linked with obesity (Delavari,
Forouzanfar, Akikhani, Sharifian, & Kelishadi, 2009). In particular, lead exposure inhibits the
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release of growth hormones (Brochin et al., 2011) and increases insulin release, both of which
are linked to obesity (Delavari et al., 2009).
Effects on blood lipid levels. Lastly, blood lipid levels are another component of
metabolic syndrome that is impacted by exposure of lead on the endocrine system. It
hypothesized in the Kristal-Boneh, Coller, Froom, Harari, and Ribak (1999) study that the
release of enzymes needed to metabolize lipids in the bloodstream are impeded by exposure to
lead, thus causing the lipid levels to accumulate and remain within the body. Growth hormone
deficiencies are also associated with increased total cholesterol and decreased HDL cholesterol
levels; as previous discussed lead is an inhibitor of growth hormones release (Kristal-Boneh et
al., 1999).
Evidence suggests that the delicate functioning of the endocrine system can easily be
disturbed by the exposure of heavy metals such as lead. The previously discussed metabolic
functions are governed by the endocrine system. However, with the disturbed homeostasis of the
endocrine system, disorders such as metabolic syndrome can develop.
Metabolic Syndrome
MetS is a grouping of risk factors associated with the development of atherosclerotic
cardiovascular disease. It is comprised of five components: elevated blood pressure, elevated
blood glucose levels, a larger waist circumference, elevated blood lipid levels and low HDL
(Huang, 2009). Defining criteria for MetS as developed by the National Cholesterol Education
Program (NCEP) Adult Treatment Plan (ATP) III in 2001 for adult populations and is
summarized in Table 1 (Akbaraly et al., 2010). Based on the definitions by the American Heart
Association and the National Heart, Lung, and Blood Institute diagnosis of MetS is diagnosed
when a patient has three of the five conditions noted in Table 1 from NCEP ATP III (Grundy et
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al., 2004). Since it is known that the disruption of the endocrine systems has the potential to lead
to MetS, we will examine whether lead exposure can be associated with the development of
MetS.
Table 1
NCEP ATP III Criteria for Metabolic Syndrome*
Risk Factor
Blood Pressure
Blood Glucose Level
Blood Triglycerides Level
HDL Cholesterol
Men
Women
Waist Circumference
Men
Women

Defining Criteria
> 130 systolic/> 85 diastolic mmHg
> 100 mg/dL
> 150 mg/dL
< 40 mg/dL
< 50 mg/dL
> 102 cm (> 40 in)
> 88 cm (>35 in)

*According to the National Cholesterol Education Program (NCEP) Adult Treatment Plan III. Copied verbatim from
Grundy, Brewer, Cleeman, Smith, & Lenfant, 2004, p. 3.

Methods
Data Source and Study Design
Data were obtained from the 2013 to 2014 NHANES population-based survey. The
survey collects health and nutritional information about noninstitutionalized U.S. individuals
every two years. The purpose of the survey is to collect a representative sample of the U.S.
population. All consent documents, brochures, and operational manuals for the 2013 to 2014
dataset are available online, at the NHANES website that is part of the CDC.
In the 2013 to 2014 survey cycle a total of 14,332 persons were selected from 30
different survey locations. From those selected 10,175 completed the interview and 9,813 were
examined. Participants were examined at a mobile examination center (MEC), where physical
assessments, laboratory measurements and examinations were conducted. Testing of serum
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samples were conducted by the CDC’s Division of Laboratory Sciences of National Center for
Environmental Health (CDC, 2015).
From the 2013 to 2014 dataset, individuals with available blood lead samples and data for
the five components of MetS (waist circumference, blood pressure, glucose, triglycerides and
HDL) were included in the analysis. The final sample size was N = 5,215.
Cofounders
Socioeconomic and sociodemographic information (i.e., age, race/ethnicity, gender,
smoking status and income) were collected as part of the NHANES Family Questionnaire by the
Computer-Assisted Personal interview (CAPI) system. Race/ethnicity was reported as Hispanic,
non-Hispanic White, non-Hispanic Black, and other multi-racial; with Hispanic as the referent
group. Income was reported as <$25000, $25000-$54999, and >$55000; <$25000 was the
referent group. Smoking status was determined by utilizing the serum cotinine levels in blood
samples that were obtained at the MEC. Categories for smoking status were broken down into
‘Never’, ‘Ex-smoker’, and ‘Current smoker’. The never smoked category is the referent group.
Laboratory Procedures and Examination
All measurements were taken at a MEC (CDC, 2015). Waist circumference, weight and
height were measured by trained health professionals. A retractable steel measuring tape was
used for waist circumference measurements in centimeters (cm), a digital scale was used for
weight in kilograms (kg) and a stadiometer was used for height measurements in meters (m).
Blood pressure measurements (systolic and diastolic) were also taken at a MEC. Three
consecutive readings were taken from the right arm of the participant; the left arm was only used
if there was a problem with the right arm. If a participant has any issues with both arms (casts,
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paralysis, rashes, edema, open sores, any dressings, wounds and/or if the cuff does not fit) the
participants were excused from this part of the examination (CDC, 2015).
Fasting glucose, triglycerides and HDL levels were tested on all participants samples,
with the blood samples were collected at the MEC and sent to the testing labs (CDC, 2015).
Metabolic Syndrome Determination
Clinical criteria determinations for MetS are listed in Table 1. The criteria are based on
the NCEP Adult Treatment Plan (ATP) III (Akbaraly et al., 2010). A diagnosis of MetS is made
if a subject has at least three of the five criteria outlined in Table 1 (Grundy et al., 2004). Male
and female participants are characterized as having MetS when they met the recommended
gender specific criteria in Table 1.
Statistical Analysis
Data analyses were conducted using the Statistical Package for Social Science (SPSS).
Descriptive statistics for continuous variables were generated for the overall sample population
and at the median value for both genders. This includes measures of centrality and dispersion.
Frequency distributions were computed for all categorical variables (smoking, income,
race/ethnicity) and MetS criteria (waist circumference, blood pressure, triglycerides, HDL, and
blood glucose levels).
To test statistical significance for continuous variable across gender, a 2-tailed t-test at an
α=0.05 level of significance was used. The testing of statistical significance for categorical
variables across gender utilized a chi-square test. BLL was dichotomized at the median into a
low exposure group (<1.23 ug/dL) and high exposure group (≥1.23 ug/dL) for males and a low
exposure group (<0.86 ug/dL) and high exposure group (≥0.86 ug/dL) for females.
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An unadjusted logistic regression was conducted to assess the odds ratio (OR), 95%
confidence interval (CI) and p-value of MetS with high exposure to BLL. A bivariate adjusted
logistic regression model was built-up beginning with first regressing the effect of high BLL on
MetS. In the next step, one variable was introduced at a time and the OR, 95% CI and p-value for
the effect on BLL was reported. In the subsequent steps this variable was removed and another
one was introduced to test its impact on BLL and MetS.
Finally, a multivariable logistic regression was carried out for MetS, with MetS being the
outcome or dependent variable. Covariates included age, income levels, race/ethnicity and
smoking status.
Results
Descriptive Statistics
The sample for this study included 1,061 participants aged 20 and older. Table 2
illustrates the demographic profile of the sample by gender and by amount of lead exposure. The
median BLL for adults aged 20 years and older was 1.03 ug/dL; with males (1.23ug/dL) having a
higher median BLL than females (0.86 ug/dL). The mean ages for males and females are similar;
males 49.6 years of age and females 48.8 years of age. Race distribution was predominately nonHispanic Whites, with 45.30% of males and 46.80% of females identifying as non-Hispanic
White. The predominant income was >$55000 (high income) with 37.50% in males and 37.90%
in females. As for smoking 22.20% were current smokers in males. In the female sample 17.60%
were current smokers. BMI distribution was comparable, both males and females were within the
overweight category, mean values for males were 28.13 and 29.68 for females.

LEAD EXPOSURE AND METABOLIC SYNDROME
Table 2
Characteristics of 2013-2014 NHANES Adult Participants and Metabolic Factors by Gender

Note: NHW, Non-Hispanic White; NHB, Non-Hispanic Black; BMI, Body Mass Index; BP, Blood Pressure; TG, Triglycerides; FBG, Fasting Blood Glucose; WC, Waist
Circumference; HDL, High Density Lipoproteins
*Waist circumference and high density lipoproteins cutoff values for males
†Waist circumference and high density lipoproteins cutoff values for females
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Amongst the males 57.5% had MetS, while only 38.6% of females had MetS.
Furthermore, 78.5% of the females who had low exposure to lead met the MetS criteria for blood
pressure, whereas 81.7% of the females who had high exposure met the criteria. In addition,
females met the MetS criteria for larger waist circumference and low HDL levels; 68.6% and
69.5% respectively when compared to males.
Logistic Regression Analysis
Bivariate logistic regression results. As illustrated in Table 3 males with high exposure
to BLL did not have a significant association with MetS, neither in the unadjusted nor the
bivariate adjusted models. For females, in the unadjusted models high BLL was associated with
55% increased risk of MetS, OR=1.55 (1.08-2.20), p = .015. However, when adjusted for all
other risk, high BLL in females was not associated with MetS.
Table 3
Bivariate Adjusted Odds Ratio (OR) and 95% Confidence Interval for Blood Lead Levels and
Risk Factors of Metabolic Syndrome in Males and Females

Characteristics
Blood Lead
Age
Race/Ethnicity
Annual Income
Smoking Status
BMI

Male
Adjusted OR (95%
CI)
0.815 (0.576-1.15)
0.599 (0.409-0.877)
0.593 (0.404-0.869)
0.524 (0.349-0.786)
0.537 (0.354-0.825)
0.741 (0.464-1.18)

p-Value
0.249
0.008
0.007
0.002
0.003
0.209

Female
Adjusted OR (95%
CI)
1.55 (1.08-2.20)
0.758 (0.498-1.15)
0.742 (0.487-1.13)
0.727 (0.472-1.12)
0.672 (0.430-1.05)
0.921 (0.563-1.51)

p-value
0.015
0.196
0.167
0.148
0.082
0.745

Note: CI, Confidence Interval; BMI, Body Mass Index

Multivariable logistic regression results. After adjusting for all risk factors in the
multivariable model illustrated in Table 4, neither men nor women had any increased risk for
MetS in the high blood lead group compared to the low blood lead group.
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Table 4
Multivariable Adjusted Odds Ratio (OR) for Blood Lead Levels and Risk Factors of Metabolic
Syndrome

Characteristic
Blood Lead (ug/dL)
Age in years
Race/Ethnicity
NHW vs. Hispanic/others
NHB vs. Hispanic/others
Annual Income
$25000-$54999 vs.
<$25000
$55000+ vs. <$25000
Smoking
Ex vs. Never
Current vs. Never
BMI (kg/m**2)

Males
Adjusted OR
(95%CI)
p-value
0.741 (0.464-1.20)
0.209
1.03 (1.01-1.04)
0.001

Females
Adjusted OR
(95%CI)
p-value
0.921 (0.563-1.51)
0.745
1.06 (1.041-1.08)
0.001

0.751 (0.466-1.21)
0.635 (0.343-1.20)

0.239
0.166

0.715 (0.431-1.19)
0.688 (0.360-1.32)

0.194
0.253

0.717 (0.420-1.23)
0.562 (0.331-0.954)

0.246
0.035

1.97 (1.13-3.46)
1.56 (0.906-2.68)

0.018
0.109

1.422 (0.853-2.40)
1.345 (0.746-2.243)
1.240 (1.174-1.300)

0.204
0.423
0.001

1.59 (0.853-2.99)
1.95 (1.05-3.62)
1.16 (1.12-1.20)

0.143
0.035
0.001

Note: CI, Confidence Interval; NHW, Non-Hispanic White; NHB, Non-Hispanic Black; BMI, Body Mass Index

A one-unit increase in age and BMI was associated with 3% and 24% greater odds of
MetS in males and were statistically significant. In race/ethnicity, non-Hispanic Whites and nonHispanic Blacks when compared to Hispanic/others had a protective factor for MetS although
this not statistically significant. For annual income both categories had a protective factor, with
high income vs. low income reaching statistical significance.
In females, a one unit increase in age and BMI showed 6% and 16% respectively greater
odds of MetS and were statistically significant [OR=1.06, 95% CI=1.04-1.08, p = .001 and
OR=1.16, 95% CI=1.12-1.20, p = .001]. Greater odds of MetS were also shown in middle
income vs. low income category, as well as the current vs. never smoking category [OR=1.97,
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95% CI= 1.13-3.46 and OR=1.95, 95% CI= 1.05-3.62]. Both odds were statistically significant
with p = .018 and p = .035 respectively.
Discussion
In this cross-sectional analysis of the NHANES 2013 to 2014 data, blood lead was not
associated with MetS in U.S. adult males and females aged 20 years older in adjusted models.
Although in the unadjusted analysis, females had 55% significantly higher risk of MetS within
the high mean blood lead groups as compared to the low group, this association was not
significant once we adjusted for confounders.
Earlier studies have shown a positive association between lead exposure and
hypertension (Gambelunghe et al., 2016), waist circumference (Delavari et al., 2009) and blood
lipid levels (Kristal-Boneh et al., 1999). The study on lead exposure by Kristal-Boneh et al.,
(1999) was based on occupational lead exposure (high exposure) which is not generalizable to
the U.S. general population exposure that currently has very low mean blood lead levels (0.76
ug/dL in males). In contrast to our study a Korean study reported significant association between
blood lead and MetS, however their blood lead levels were 2.08 ug/dL, which is significantly
higher than the blood lead levels reported for the sample in the present study (Moon, 2013).
The prevalence of MetS in our studied population which is representative of the U.S.
population was nearly 58%. Based on published reports the prevalence of MetS in the U.S. adult
population has been increasing over the years as evidenced by the rising rates of MetS in
NHANES datasets 2003 to 2004 (32.9%) compared to 2011 to 2012 (34.7%) (Aguilar et al,.
2015). The highest MetS prevalence of 2014 where 38.6% for Hispanics, 37.4% for nonHispanic Whites, and over 50% in women and Hispanics older than 60 years of age (Aguilar et
al., 2015). In other international studies it has been reported that there is an increasing magnitude
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of MetS prevalence. The overall MetS prevalence in adults over the age of 45 had a prevalence
above 50% (Delavari et al., 2009); which concurs with other studies, suggesting that the
worldwide prevalence is on the rise.
Strengths
Strengths in this study include the usage of information from NHANES which is a
nationally representative dataset and characterizing both genders and multiple ethnicities. Due to
rigorous NHANES methodology bias is limited, the national survey uses intensive training that
helps with prevention of selection and interview bias and uses state of the art laboratory
facilities. This study is high in internal validity; we adjusted for a number of confounding
variables including age, annual income, race/ethnicity and smoking status. Since NHANES is an
excellent representation of the general population it has external validity.
Limitations
Limitations of this study include the cross-sectional nature of the NHANES data which
does not allow studying temporality, one of the criteria for causality. The sample size for males
and females was a little over 500 participants for each. In future studies a larger sample size
could possibly be used by combining data from different survey cycles. Future areas of study
could look at the impact of lead exposure in those younger than 20 years of age, as chronic
diseases have been on the rise in children and adolescents.
Conclusion
Based on the results of our study, lead exposure in U.S. adults aged 20 years and older
does not have a statistically significant association with the prevalence of MetS in both males
and females. Further analysis and identification of factors that contribute to the lack of
significance will need additional evaluation.
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Appendix B: List of Competencies Met in Integrative Learning Experience
CEPH Foundational Competencies Checklist
Evidence-based Approaches to Public Health
2. Select quantitative and qualitative data collection methods appropriate for a given public health context
3. Analyze quantitative and qualitative data using biostatistics, informatics, computer-based programming and
software, as appropriate
4. Interpret results of data analysis for public health research, policy or practice
Communication
19. Communicate audience-appropriate public health content, both in writing and through oral presentation

Concentration Specific Competencies Checklist
Population Health Concentration
2. Demonstrate application of an advanced quantitative or qualitative research methodology.
3. Demonstrate the ability to contextualize and integrate knowledge of specific population health issues.
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